Novel serum proteomic biomarkers for early diagnosis and aggressive grade identification of prostate cancer

BACKGROUND: Prostate cancer (PCa) is one of the most common tumors and the second leading cause of cancer-related death in men. The discovery of novel biomarkers for PCa diagnosis in the early stage, as well as discriminating aggressive PCa from non-aggressive PCa continue to pose a challenge. The a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ce, Liu, Guangming, Liu, Yehua, Yang, Zhanpo, Xin, Weiwei, Wang, Meng, Li, Yang, Yang, Lan, Mu, Hong, Zhou, Chunlei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582260/
https://www.ncbi.nlm.nih.gov/pubmed/36276156
http://dx.doi.org/10.3389/fonc.2022.1004015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582260/
https://www.ncbi.nlm.nih.gov/pubmed/36276156
http://dx.doi.org/10.3389/fonc.2022.1004015

Ejemplares similares